Evommune, Inc. Common Stock (EVMN)
R&D Expenses
$83.77M
TTM · Period ending: · USD
EVMN R&D Expenses
Latest reported$83.77Mperiod ending
Latest reported$83.77Mperiod ending
EVMN R&D Expenses ($32.00M → $83.77M)
Annual R&D Expenses
High-resolution chart · PNG
EVMN r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 74,042,000 | |
| 64,244,000 | |
| 31,997,000 |